EN
Press Releases
-
2022/06/02
SINOVAC Polio Vaccine Prequalified by WHO
![SINOVAC Polio Vaccine Prequalified by WHO]()
BEIJING--SINOVAC Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received the World Heal
-
On May 20, 2022, the Public Health Institute of Chile (ISP) released the fourth statistical report "AEFIs after the administration of SARS-CoV-2 vaccines in Chile in the pediatric and adolescent
-
![SINOVAC Honored]()
May 9, 2022 – Jakarta, Indonesia – SINOVAC Biotech Ltd., (SINOVAC), a leading provider of biopharmaceutical products in China, has been honored with the "MITRA BUMN GLOBAL CHAMPION 2022" awa
-
![SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual Report on Form 20-F]()
BEIJING, China--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2021 annual report on Form 20-F with the U.S.
-
![China NMPA approved SINOVAC Omicron-specific vaccine for clinical trial]()
April 26, 2022, Sinovac Biotech Ltd. (“SINOVAC”) announced that its inactivated COVID-19 vaccine (Omicron strain) has been approved for clinical trial in China. SINOVAC continuously carried out the de
-
![SINOVAC Omicron-specific vaccine approved for clinical trial in Hong Kong]()
April 14, 2022, Sinovac Biotech Ltd. (“SINOVAC”) announced that its inactivated COVID-19 vaccine (Omicron strain) has been approved for clinical trial in Hong Kong, China. SINOVAC continuously carrie
-
2022/03/23
Three doses of SINOVAC COVID-19 vaccine well prevent the worst outcomes during HK Omicron wave
![Three doses of SINOVAC COVID-19 vaccine well prevent the worst outcomes during HK Omicron wave]()
A study of University of Hong Kong revealed that three shots of CoronaVac offered appromixtely 98% protection against death or severe illness in those over 60 years old, underscoring the importance of
-
![Chile Research: CoronaVac<sup>®</sup> is safe and likely to confer protection against infection caused by SARS-CoV-2 variants in participants aged 3-17 years old]()
The inactivated COVID-19 vaccine CoronaVac®, innovated and manufactured by Sinovac Biotech LTD. (SINOVAC), has been widely used in Chilean minors since September 2021. Recently, an interim safety and
-
![Chile Study: The World's First Real-World Study on the Effectiveness of CoronaVac Among Children 3 to 5 Years Old During Omicron Outbreak]()
On Mar. 15, 2022, a real-world study report accessed the effectiveness of an inactivated SARS-CoV-2 vaccine (CoronaVac) in children 3 to 5 years old in Chile during the prevalence of Omicron was recen
-
![Latest Real-World Data Show Two-shots of CoronaVac<sup>®</sup> Provides 74.5% Protection Against COVID-19 For Children and Adolescents]()
Real-world data show effectiveness of CoronaVac® 74.5% for prevent of COVID-19, 91.0% for hospitalisation and 93.8% for ICU admission in children and adolescents aged 6 to 16 years old· 95% of indivi
-
![Brazilian Study: Due to the vaccination roll-out applied to elderly: 167,000 hospitalizations and 77,000 lives were avoided]()
During the past two years, the covid-19 pandemic affected almost all people in the world, and every aspect of people’s lives has been affected. The elderly, those were considered the most vulnerable p
-
![CUHK and SINOVAC Biotech (Hong Kong) Limited strategic collaboration framework agreement signing ceremony]()
Represented by: Professor Rocky S. TUAN, Vice-Chancellor and President of CUHK, Mr. Weidong YIN, Chairman, President, and CEO of SINOVAC Biotech Limited Witnessed by:Professor Wai Yee CHAN, Pro-Vice-C
-
![CUHK and SINOVAC join in hands in building P3 laboratory]()
Developing the city into high ground for biomedical sciencesThe Chinese University of Hong Kong (CUHK) and Sinovac Biotech (Hong Kong) Limited (SINOVAC) signed a new Strategic Collaboration Framework
